STOCK TITAN

Cannabist Company Holdings (OTC: CBSTF) ends S-3 offerings after CCAA/Chapter 15

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
POS AM

Rhea-AI Filing Summary

The Cannabist Company Holdings Inc. is terminating its Form S-3 registration statements and deregistering all unsold securities registered thereunder.

The registrations covered up to an aggregate offering price of $250,000,000 under Registration No. 333-275821 and 84,426,229 shares of common stock under Registration No. 333-278472. The deregistration follows the commencement of CCAA proceedings in Ontario and voluntary Chapter 15 petitions filed in the U.S.

Positive

  • None.

Negative

  • None.

Insights

Deregistration aligns with cross-border insolvency proceedings.

The filings state the company and its debtor affiliate commenced a Canadian CCAA proceeding and filed Chapter 15 petitions in Delaware, and have terminated the S-3 offerings and deregistered all unsold securities.

Key dependencies include the court-supervised restructuring process in the Ontario Superior Court and recognition actions in the U.S.; subsequent disclosures in court filings will determine creditor recoveries and any future securities actions.

As filed with the Securities and Exchange Commission on March 25, 2026

Registration No. 333-275821
Registration No. 333-278472

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Post-Effective Amendment No. 1 to
Form S-3 Registration Statement File No. 333-275821
Form S-3 Registration Statement File No. 333-278472
Under
The Securities Act of 1933
THE CANNABIST COMPANY HOLDINGS INC.
(Exact name of the registrant as specified in its charter)
 
British Columbia
(State or other jurisdiction of incorporation or organization)
 
98-1488978
(I.R.S. Employer Identification No.)

321 Billerica Road
Chelmsford, MA 01824
(978) 910-1486
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

David Sirolly
Chief Legal Officer & General Counsel
The Cannabist Company Holdings Inc.
321 Billerica Road
Chelmsford, MA 01824
(978) 910-1486
(Name and address agent for service)
 
Copies to:
Weil, Gotshal & Manges LLP
767 5th Ave
New York, NY 10153
(212) 310-8000
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



DEREGISTRATION OF UNSOLD SECURITIES

These Post-Effective Amendments (the “Post-Effective Amendments”), filed by The Cannabist Company Holdings Inc., a British Columbia, Canada corporation (the “Registrant”), relate to the following Registration Statements on Form S-3 and any amendments previously filed by the Registrant (the “Registration Statements”) with the Securities and Exchange Commission (the “SEC”):
 
Registration
No.
Date Originally Filed
With the SEC
Number of Common Shares Registered
333-275821
November 30, 2023
Up to an aggregate offering price of $250,000,000 of any combination of Registrant’s securities
333-278472
April 2, 2024
84,426,229 shares of common stock, issued upon the conversion of certain senior secured convertible debentures issued on March 19, 2024, for resale by selling stockholders

On March 24, 2026, the Registrant and its debtor affiliate, the Cannabist Company Holdings (Canada) Inc. (together, the “Debtors”), commenced a proceeding under the jurisdiction of the Ontario Superior Court of Justice (Commercial List) pursuant to the Companies’ Creditors Arrangement Act (the “CCAA”) (the “Canadian Proceeding”). On March 25, 2026, the Debtors filed voluntary petitions for relief under chapter 15 of title 11 of the United States Code (such cases, the “Chapter 15 Cases”) in the United States Bankruptcy Court for the District of Delaware. In connection with the Canadian Proceeding and the filing of the Chapter 15 Cases, the Registrant is terminating all offerings of its securities pursuant to the existing registration statements under the Securities Act of 1933, including the Registration Statements.
 
Pursuant to the undertaking made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities that had been registered for issuance that remain unsold at the termination of the offering, the Registrant is filing these Post-Effective Amendments to terminate the effectiveness of the Registration Statements and to deregister, as of the effectiveness of these Post-Effective Amendments, any and all securities of the Registrant registered thereunder that remain unsold as of the effectiveness date. As a result of this deregistration and upon the effectiveness of these Post-Effective Amendments, no securities will remain registered pursuant to the Registration Statements.
 

SIGNATURE
 
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Chelmsford, State of Massachusetts, on March 25, 2026.
 
 
THE CANNABIST COMPANY HOLDINGS INC.
   
 
By: /s/ David Sirolly
 
Name: David Sirolly
Title: Chief Legal Officer & General Counsel

Note: No other person is required to sign these Post-Effective Amendments in reliance upon Rule 478 under the Securities Act of 1933.



FAQ

What did the March 25, 2026 POS AM say about CBSTF's registered offerings?

The amendment states the company is terminating its S-3 registrations and deregistering unsold securities. It references Registration Nos. 333-275821 and 333-278472 and the related amounts registered for resale and primary issuance.

How many shares were registered for resale under Registration No. 333-278472 for CBSTF?

Registration No. 333-278472 registered 84,426,229 shares of common stock for resale. The post-effective amendment states those registered securities are being deregistered as of the amendment's effectiveness.

What aggregate amount was registered under Registration No. 333-275821 for CBSTF?

Registration No. 333-275821 registered up to an aggregate offering price of $250,000,000 of securities in any combination. The post-effective amendment terminates that registration and deregisters any unsold securities.

Why did CBSTF file the post-effective amendments to deregister securities?

The company states the deregistration follows commencement of CCAA proceedings in Ontario and voluntary Chapter 15 petitions in the U.S., triggering its undertaking to remove unsold registered securities by post-effective amendment.

Will any securities remain registered under those S-3 filings after the amendment?

No. The amendment states that, upon effectiveness, no securities will remain registered pursuant to the identified Registration Statements.
Cannabist

OTC:CBSTF

View CBSTF Stock Overview

CBSTF Rankings

CBSTF Latest News

CBSTF Latest SEC Filings

CBSTF Stock Data

14.43M
507.40M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Chelmsford